Nearly all planned 44,000 participants enrolled in final-stage trial. If found safe, vaccine could see use in November.
from Home - CBSNews.com https://ift.tt/3kDIRKE
from Home - CBSNews.com https://ift.tt/3kDIRKE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment